Peripheral/Endo

Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers

RESEARCH TRIANGLE PARK, N.C., April 07, 2026 (GLOBE NEWSWIRE) — Merakris Therapeutics today provided an update on recent communications with the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug (IND) application for MTX-001, an investigational biologic being developed for venous leg ulcers (VLUs).

Shape Memory Medical Begins Enrollment in FLAGSHIP Study Evaluating Novel False Lumen Embolization Technology

SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular applications, today announced enrollment of the first patients in FLAGSHIP, the Company’s prospective, single‑arm, open‑label first‑in‑human study evaluating its investigational False Lumen Embolization (FLE) System for the treatment of aortic dissection. Aortic dissection is a life‑threatening condition in which a tear in the aortic wall creates a secondary channel known as

Endovascular Engineering Announces Dual Late-Breaking Presentations at SIR and SCAI 2026 Highlighting Validation of Blood Return and Comprehensive ENGULF Study Results

MENLO PARK, Calif., March 19, 2026 /PRNewswire/ — Endovascular Engineering, Inc. (“E2”) today announced that two abstracts related to the ENGULF study and the Hēlo® Platform have been accepted as late-breaking podium presentations at the Society of Interventional Radiology (SIR) Annual…